| Product Code: ETC9559998 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Sweden saw a steady import flow of multiplex biomarker imaging systems, with top exporters being Germany, Japan, Metropolitan France, USA, and the Netherlands. The market displayed low concentration with a stable Herfindahl-Hirschman Index (HHI). Despite a modest compound annual growth rate (CAGR) of 2.02% from 2020 to 2024, there was a slight decline in growth rate from 2023 to 2024 at -3.13%. These trends indicate a consistent demand for advanced biomarker imaging technologies in Sweden, with opportunities for further market expansion and diversification in the near future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Multiplex Biomarker Imaging Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Multiplex Biomarker Imaging Market - Industry Life Cycle |
3.4 Sweden Multiplex Biomarker Imaging Market - Porter's Five Forces |
3.5 Sweden Multiplex Biomarker Imaging Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 Sweden Multiplex Biomarker Imaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Sweden Multiplex Biomarker Imaging Market Revenues & Volume Share, By Imaging Techniques, 2021 & 2031F |
3.8 Sweden Multiplex Biomarker Imaging Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Sweden Multiplex Biomarker Imaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Sweden requiring advanced diagnostic techniques. |
4.2.2 Growing investments in healthcare infrastructure and research and development activities. |
4.2.3 Rising demand for personalized medicine and targeted therapies using biomarker imaging technologies. |
4.3 Market Restraints |
4.3.1 High initial capital investment and operating costs associated with multiplex biomarker imaging systems. |
4.3.2 Stringent regulatory requirements and lengthy approval processes for new biomarker imaging technologies. |
5 Sweden Multiplex Biomarker Imaging Market Trends |
6 Sweden Multiplex Biomarker Imaging Market, By Types |
6.1 Sweden Multiplex Biomarker Imaging Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Software, 2021- 2031F |
6.1.5 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Services, 2021- 2031F |
6.2 Sweden Multiplex Biomarker Imaging Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Drug Safety, 2021- 2031F |
6.2.3 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Oncology Studies, 2021- 2031F |
6.2.4 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Genetic Characterization Studies, 2021- 2031F |
6.3 Sweden Multiplex Biomarker Imaging Market, By Imaging Techniques |
6.3.1 Overview and Analysis |
6.3.2 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Immuno Fluorescence Assay, 2021- 2031F |
6.3.3 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Tissue Microarray Assay, 2021- 2031F |
6.3.4 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Immunohistochemistry Assay, 2021- 2031F |
6.3.5 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Fluorescent in the Situ Hybridization Assay, 2021- 2031F |
6.3.6 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Toponome Imaging System, 2021- 2031F |
6.4 Sweden Multiplex Biomarker Imaging Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Research Institutes Government & Private, 2021- 2031F |
6.4.3 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Pharmaceutical & Biotechnology, 2021- 2031F |
6.4.4 Sweden Multiplex Biomarker Imaging Market Revenues & Volume, By Clinical Labs, 2021- 2031F |
7 Sweden Multiplex Biomarker Imaging Market Import-Export Trade Statistics |
7.1 Sweden Multiplex Biomarker Imaging Market Export to Major Countries |
7.2 Sweden Multiplex Biomarker Imaging Market Imports from Major Countries |
8 Sweden Multiplex Biomarker Imaging Market Key Performance Indicators |
8.1 Adoption rate of multiplex biomarker imaging technologies in Sweden. |
8.2 Number of research collaborations and partnerships for biomarker imaging technology development. |
8.3 Rate of technological advancements and innovations in multiplex biomarker imaging techniques. |
9 Sweden Multiplex Biomarker Imaging Market - Opportunity Assessment |
9.1 Sweden Multiplex Biomarker Imaging Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 Sweden Multiplex Biomarker Imaging Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Sweden Multiplex Biomarker Imaging Market Opportunity Assessment, By Imaging Techniques, 2021 & 2031F |
9.4 Sweden Multiplex Biomarker Imaging Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Sweden Multiplex Biomarker Imaging Market - Competitive Landscape |
10.1 Sweden Multiplex Biomarker Imaging Market Revenue Share, By Companies, 2024 |
10.2 Sweden Multiplex Biomarker Imaging Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here